Depression
Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.
RecruitingACTRN12611000264987
Official study titleA randomised controlled trial to investigate the effectiveness of a model of integrated, evidence based management of modifiable cardiovascular risk factors and post stroke depression, in stroke survivors returning to the care of their general practitioner.
Location not clearly listedDepressionInterventional studyAges 18+
- Countries
- Sponsor
- National Ageing Research Institute (NARI) of Melbourne.
RecruitingISRCTN77976141
In United KingdomDepressionResearch studyAges 18+
- Countries
- United Kingdom
- Sponsor
- University College London
RecruitingACTRN12605000145606
Official study titleRepetitive Transcranial Magnetic Stimulation (rTMS) in the treatment of depression, assessed with HAMD-21 over a four week period.
Location not clearly listedDepressionInterventional study
- Countries
- Sponsor
- Centre for Clinical Research in Neuropsychiatry
RecruitingACTRN12614000816651
Official study titleEvaluation of a single session of Brief Behavioural Activation for Treatment for Depression (BATD): A randomised control trial in a community sample of individuals meeting diagnostic criteria for depression.
In AustraliaDepressionInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- School of Psychology and Speech Pathology, Curtin University
RecruitingISRCTN10648713
In United KingdomDepressionResearch studyAges 18–65
- Countries
- United Kingdom
- Sponsor
- King's College London (University)
RecruitingACTRN12624000613505
Official study titleThings You Do (TYD) RCT #2: Randomised Controlled Trial comparing the efficacy of TYD Intervention vs. Gratitude Intervention vs. Waitlist Control for reducing symptom severity in health professionals experiencing anxiety or depression (“SMS Wellbeing Trial”)
In AustraliaDepression, AnxietyInterventional studyAges 18+
- Countries
- Australia
- Sponsor
- Macquarie University
RecruitingACTRN12606000371594
Official study titleA cluster randomised controlled trial designed to investigate the impact on the prevalence and severity of depression, in patients with chronic manifestations of ischaemic heart disease.
Location not clearly listedDepressionInterventional studyAges 18–85
- Countries
- Sponsor
- NHMRC
RecruitingNCT06725277
About this title
The OBSERVE Protocol
Read the official source — NCT06725277Official study titleComparative Effectiveness of Racemic Ketamine Versus Esketamine (Spravato®) for Depression: The OBSERVE Protocol
Multiple locations, including MilfordDepressionObservational study
- Countries
- United States
- Sponsor
- Yale University
RecruitingACTRN12615000931572
Official study titleThe springboarD trial: Trial of a self-help intervention to improve functioning and emotional well-being for depression and diabetes-related distress in people with type 2 diabetes
In AustraliaDepressionInterventional studyAges 18–75
- Countries
- Australia
- Sponsor
- Black Dog Institute; University of New South Wales
RecruitingACTRN12614000297628
Official study titleIn children and adolescents (aged 7-14) attending Child and Adolescent Mental Health Services (CAMHS) for depression, anxiety, trauma or conduct problems does the Modular Approach to Therapy for Children (MATCH-ADTC), compared to usual care, improve clinical outcomes (measured by comparing difference in trajectory of change of clinical severity)?
In New ZealandDepression, AnxietyInterventional studyAges 7–14
- Countries
- New Zealand
- Sponsor
- Health Research Council (HRC)
RecruitingACTRN12616001561471
Official study titleTreatment of Adolescents with Depression (TRACED): A pilot study on Acute Tryptophan Depletion as a predictor for treatment response
In AustraliaDepressionInterventional studyAges 12–17
- Countries
- Australia
- Sponsor
- The Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, The University of Western Australia
RecruitingACTRN12605000675628
Official study titleA cross-over study to evaluate the effects of a cognitive behavioural therapy (CBT) intervention, followed by a randomised trial of sertraline/placebo (for non-responders to CBT only) in the treatment of comorbid depression and substance misuse to improve outcome in depression and substance use levels.
Location not clearly listedDepression, AddictionInterventional studyAges 16–26
- Countries
- Sponsor
- Melbourne Health